The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the process of negotiating prices for certain Medicare Part D drugs with input fro | The agency said it is "considering opportunities to bring greater transparency" and will consider stakeholder feedback on the program.
An expanding prohibition on third-party financial guarantees could lead to more nursing home using lawsuits to collect unpaid debt.
In his first confirmation hearing, Robert F. Kennedy Jr. tried to distance himself from his past statements on abortion and vaccines
The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level standards applied to eligibility criteria for Medicaid.
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation hearing to become the next secretary of Health and Human Services.
Given the prevalence of managed care, it’s incumbent upon the industry to ensure that there is a robust supplier pool.
Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.
Congress and Republican President Donald Trump have made it clear they intend to consider far-reaching policies to limit the scope of Medicaid in the name of slashing government spending.
Access to the State of Alabama’s Medicaid portal has been temporarily closed. This closure comes after a federal loan and grant funding freeze issued by President Donald Trump. No word on what this closure will mean for Medicaid and SNAP benefit recipients.
Healthcare Management Solutions LLC can perform a $41 million auditing services task order for the Centers of Medicare and Medicaid Services despite the agency’s improper discussions, the US Court of Federal Claims said.
According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and Africa $432.7 million. This growing demand emphasizes the strategic importance of INBS' partnership with IVY Diagnostics.